Vaccinating against HIV has been a decades-long effort, stymied by the virus’s high mutation rate and mask of human glycans.
A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results